TipRanks
Advertisement
Advertisement

MAYNF Stock Latest News

FDA clears IMVEXXY post-marketing obligations as Mayne Pharma targets U.S. menopause growth
Company AnnouncementsFDA clears IMVEXXY post-marketing obligations as Mayne Pharma targets U.S. menopause growth
1d ago
Mayne Pharma Performance Rights Lapse After Vesting Conditions Not Met
PremiumCompany Announcements
Mayne Pharma Performance Rights Lapse After Vesting Conditions Not Met
3d ago
Mayne Pharma Secures Long-Term IMVEXXY Patent Protection in U.S. Settlement With Sun Pharma
PremiumCompany Announcements
Mayne Pharma Secures Long-Term IMVEXXY Patent Protection in U.S. Settlement With Sun Pharma
10d ago
Mayne Pharma Reaches Low-Cost Settlement With U.S. States Over Generic Drug Probe
PremiumCompany Announcements
Mayne Pharma Reaches Low-Cost Settlement With U.S. States Over Generic Drug Probe
12d ago
Mayne Pharma Sets Date for 2026 Annual General Meeting
PremiumCompany Announcements
Mayne Pharma Sets Date for 2026 Annual General Meeting
12d ago
Mayne Pharma Secures Exclusive Australian Rights to Menopause Therapy Blissel
PremiumCompany AnnouncementsMayne Pharma Secures Exclusive Australian Rights to Menopause Therapy Blissel
25d ago
Mayne Pharma Cancels Tranche of Performance Rights in Capital Management Move
Premium
Company Announcements
Mayne Pharma Cancels Tranche of Performance Rights in Capital Management Move
1M ago
Mayne Pharma Issues New Shares Following Conversion of Unquoted Securities
Premium
Company Announcements
Mayne Pharma Issues New Shares Following Conversion of Unquoted Securities
1M ago
Mayne Pharma Earnings Call: Margins Rise, Risks Linger
PremiumCompany Announcements
Mayne Pharma Earnings Call: Margins Rise, Risks Linger
1M ago
Mayne Pharma Seeks ASX Quotation for New Employee Incentive Shares
PremiumCompany Announcements
Mayne Pharma Seeks ASX Quotation for New Employee Incentive Shares
1M ago
Mayne Pharma Highlights FY26 Results and Risk Factors in Investor Update
PremiumCompany Announcements
Mayne Pharma Highlights FY26 Results and Risk Factors in Investor Update
1M ago
Mayne Pharma Posts FY26 Profit as Women’s Health and DistributeRx Drive Strategic Shift
PremiumCompany Announcements
Mayne Pharma Posts FY26 Profit as Women’s Health and DistributeRx Drive Strategic Shift
1M ago
Mayne Pharma Swings to Full-Year Profit Despite Revenue Decline
PremiumCompany AnnouncementsMayne Pharma Swings to Full-Year Profit Despite Revenue Decline
1M ago
Mayne Pharma sets date for FY26 results release and investor webcast
Premium
Company Announcements
Mayne Pharma sets date for FY26 results release and investor webcast
2M ago
Mayne Pharma bolsters menopause portfolio with new IMVEXXY safety data and BIJUVA award recognition
Premium
Company Announcements
Mayne Pharma bolsters menopause portfolio with new IMVEXXY safety data and BIJUVA award recognition
2M ago
Mayne Pharma Launches Digital Investor Hub to Boost Shareholder Engagement
PremiumCompany Announcements
Mayne Pharma Launches Digital Investor Hub to Boost Shareholder Engagement
2M ago
Mayne Pharma Adds New Director With Significant Indirect Shareholding
PremiumCompany Announcements
Mayne Pharma Adds New Director With Significant Indirect Shareholding
2M ago
Mayne Pharma Publishes CEO Presentation for Bioshares Summit
PremiumCompany Announcements
Mayne Pharma Publishes CEO Presentation for Bioshares Summit
2M ago
Mayne Pharma Reports Lapse of Performance Rights
PremiumCompany Announcements
Mayne Pharma Reports Lapse of Performance Rights
2M ago
Mayne Pharma Issues New Shares Following Option Conversions
PremiumCompany AnnouncementsMayne Pharma Issues New Shares Following Option Conversions
2M ago
Mayne Pharma Adds Major Shareholder Jacob Ma-Weaver to Board
Premium
Company Announcements
Mayne Pharma Adds Major Shareholder Jacob Ma-Weaver to Board
2M ago
Mayne Pharma CEO to Present at 20th Bioshares Summit
Premium
Company Announcements
Mayne Pharma CEO to Present at 20th Bioshares Summit
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >